{"id":"W3047097799","doi":"10.1038/s43018-020-0096-5","title":"Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab","year":2020,"lang":"en","type":"article","venue":"Nature Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":480,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research; Ontario Institute for Cancer Research; Public Health Ontario; University of Toronto; University Health Network","funders":"Department of Medical Biophysics, University of Toronto; Canada Research Chairs; Terry Fox Research Institute; Canada Foundation for Innovation; Princess Margaret Cancer Foundation","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Biomarker; Circulating tumor DNA; Clinical trial; Response Evaluation Criteria in Solid Tumors; Immunotherapy; Immune checkpoint; Cancer; Phases of clinical research; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003803739,0.0002702918,0.0004346792,0.0004286728,0.0002003454,0.0007891171,0.0002014552,0.000392428,0.000850443],"category_scores_gemma":[0.00144028,0.0001514662,0.0001700113,0.0003731427,0.0001413838,0.0003438591,0.0001533574,0.0006137087,0.0001838621],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004274244,"about_ca_system_score_gemma":0.0003104308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005838352,"about_ca_topic_score_gemma":0.001079882,"domain_scores_codex":[0.9997365,0.00007176986,0.00001939516,0.00006349501,0.00007220305,0.00003664205],"domain_scores_gemma":[0.999579,0.0001661342,0.000126177,0.00002238523,0.00004849827,0.00005781456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009019208,0.0004593374,0.6781858,0.0002200799,0.0005367016,0.001002336,0.0002258272,0.002343626,0.0638216,0.0005459865,0.003501519,0.2401381],"study_design_scores_gemma":[0.000477254,0.003713142,0.9046075,0.0001656214,0.001011693,0.003643772,0.0003695931,0.02550538,0.04529293,0.001765453,0.01338839,0.0000593724],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914458,0.004585255,0.001145129,0.0006395744,0.0001024733,0.00002297992,0.0003365623,0.00007076716,0.001651445],"genre_scores_gemma":[0.9975131,0.0006246007,0.0008819952,0.0002223769,0.00006063709,0.00001457781,0.0002384587,0.000005709149,0.0004387159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000850443,"threshold_uncertainty_score":0.00310117,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006281876612736395,"score_gpt":0.256241797350765,"score_spread":0.2499599207380286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}